Raltegravir
Raltegravir is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including Raltegravir. Available dosage forms: powder, tablet, film coated.
Drug details
- Generic Name
- Raltegravir
- Brand Names
- Raltegravir
- Application Number
- ANDA217990
- Sponsor
- Siegfried Evionnaz SA
- NDC Codes
- 4
- Dosage Forms
- POWDER, TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- RALTEGRAVIR POTASSIUM
Indications and Usage
1 INDICATIONS AND USAGE ISENTRESS® is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in patients 4 weeks of age and older. The use of other active agents with ISENTRESS is associated with a greater likelihood of treatment response [see Clinical Studies (14) ] . ISENTRESS is a human immunodeficiency virus integrase strand transfer inhibitor (HIV-1 INSTI) indicated: In combination with other antiretroviral agents for the treatment of HIV-1 infection in patients 4 weeks of age and older ( 1 ). The use of other active agents with ISENTRESS is associated with a greater likelihood of treatment response ( 14 ).